Healthy volunteers test new capsule for nervous system disorders
NCT ID NCT05938452
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This early-stage study tested the safety of a new capsule called glyceryl tribenzoate (GTB) in 40 healthy adults aged 18 to 50. Participants received either a single or multiple doses to see how the body processes the drug and if any side effects occur. The goal was not to treat any disease, but to gather important safety information for future research on neurological disorders.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROLOGICAL DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
TKL Research
Bloomfield, New Jersey, 07003, United States
Conditions
Explore the condition pages connected to this study.